Cameron Snell

Head of Anatomical Pathology

Peter MacCallum Cancer Centre

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Cameron Snell is the Head of Anatomical Pathology at Peter MacCallum Cancer Centre in Australia. His research focuses on oncological diagnostics and treatment, with recent articles addressing topics such as the molecular analysis of cutaneous sarcomatoid neoplasms, HER2-targeted therapies, and RNA-based gene fusion assays. He is also involved in studying immune biomarkers in lymphoma and the application of digital image analysis in breast cancer diagnostics.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Sonja Klebe

Flinders University

AUSTRALIA

View details

Akhilandeshwari Ravichandran

Queensland University of Technology

AUSTRALIA

View details

Sarita Prabhakaran

Flinders University

AUSTRALIA

View details

Haitham Tuffaha

University of Queensland

AUSTRALIA

View details

Sandra Brosda

University of Queensland

AUSTRALIA

View details

Julien Clegg

Demonstrator/Teaching assistant

Queensland University of Technology

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cameron Snell

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Molecular Analysis of Cutaneous Sarcomatoid Neoplasms Frequently Identifies Melanoma Driver Variants.

Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2- Breast Cancers.

The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspective.

Intra‐tumoral and peripheral blood TIGIT and PD‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma

Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency.

Development and Validation of a HER2-Low Focused Immunohistochemical Scoring System With High-Interobserver Concordance: The Australian HER2-Low Breast Cancer Concordance Study.

Exploring the Potential of PEG‐Heparin Hydrogels to Support Long‐Term Ex Vivo Culture of Patient‐Derived Breast Explant Tissues

Improved concordance of challenging human epidermal growth factor receptor 2 dual in‐situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer

Real-world prevalence of PD-L1 expression in non-small cell lung cancer

The in situ transcriptomic landscape of breast tumour-associated and normal adjacent endothelial cells.

Collaborators (6)

Sonja Klebe

Akhilandeshwari Ravichandran

Sarita Prabhakaran

Haitham Tuffaha

Sandra Brosda

Julien Clegg

Make your next move.